
Synthetic biology and artificial intelligence are converging to reshape global manufacturing, national security, and social discourse. Biotechnology is evolving into a general-purpose technology capable of biomanufacturing physical inputs, while AI accelerates biological discovery and protein engineering. This technological shift occurs within a multi-dimensional geopolitical contest between the United States and China, where success depends on leadership in frontier models, industrial applications, and global diffusion. Simultaneously, AI-driven digital environments pose significant risks to democratic stability by enabling sophisticated propaganda and altering public perception. While China leverages these tools for economic stimulus and state control, the global challenge remains to balance innovation with safety, particularly regarding biosecurity and the potential for malicious actors to exploit advanced coding and pathogen design capabilities. Effective governance requires addressing these cross-domain risks without stifling the economic and scientific potential of these transformative technologies.
Sign in to continue reading, translating and more.
Continue